📈 Stocks
Kardigan Biotech Raises $400 Million in Oversubscribed IPO for Heart Disease Therapies
(61 days ago)
Kardigan's upsized $400 million IPO for heart disease therapies highlights growing investor confidence in biotech innovation and sets a favorable precedent for…